How Oxford Medical Sciences is fighting Coronavirus
Researchers from across the Medical Sciences Division are working hard to combat the COVID-19 crises. With particular strengths in infectious diseases and international health, we are well placed to contribute to better understanding and effectively controlling the epidemic. We have a long history of responding to crises, in the UK and around the world and are leaders in emergency vaccine development. During the 2014 Ebola outbreak, our scientists performed the world’s first human Ebola vaccine studies, starting them before any other university or company. Our researchers, in collaboration with partners across the globe, are working to develop an effective vaccine and drugs to target this virus, and have already introduced innovative public health measures and collaborative online tools that are being used in hospitals here and abroad.
Support our Research
Find out how to support Oxford's coronavirus work across a number of key research areas.
Support our researchers
Opportunities for our researchers and support requests.
Coronavirus-related news from across the Medical Sciences Division
NHS garden in full bloom at RHS Chelsea Flower Show
23 September 2021
The sun was shining for the RHS Chelsea Flower show press day earlier this week. One garden in particular bloomed particularly brightly, with the 'Finding Our Way: An NHS Tribute Garden' getting plenty of attention.
QCovid highly commended for ‘best use of technology in Patient Safety’ at the 2021 HSJ Patient Safety Awards
23 September 2021
Professor Julia Hippisley-Cox and her team in Nuffield Department of Primary Care Health Sciences have been Highly Commended in the ‘Best use of technology in Patient Safety’ category for the QCovid risk calculator at this year’s Health Service Journal Patient Safety Awards.
Oxford and Oracle partner to speed identification of COVID-19 variants
20 September 2021
The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.
Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool
20 September 2021
Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.
Com-COV vaccine mix-and-match study expands to 12-to-16-year-olds
20 September 2021
Researchers running the University of Oxford-led Com-COV programme have launched a new study of COVID-19 vaccination schedules in young people aged 12 to 16.
COVID-19 recovery project nominated for HSJ award
15 September 2021
The project, involving Oxford University Hospitals, Defence Medical Services (DMS), and the Radcliffe Department of Medicine is in the running for a prestigious honour at the Health Service Journal Awards 2021.
'Finding our Way: An NHS Tribute Garden' at RHS Chelsea Flower Show 2021
15 September 2021
‘Finding Our Way – An NHS Tribute Garden’ is a celebration of the incredible efforts of the thousands of people who fought – and are still fighting - the COVID-19 pandemic on our behalf. The garden is designed by Naomi Ferrett-Cohen and presented by Oxford University Hospitals NHS Foundation Trust and Oxford University.
International study finds insomnia, anxiety and depression very prevalent during first phase of COVID-19 pandemic
10 September 2021
An international sleep study has found that insomnia, anxiety, and depression were very prevalent during the first wave of the COVID-19 pandemic. Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.
Vaccine for treating cancer made possible using Oxford COVID vaccine technology
6 September 2021
Research from the University of Oxford and the Ludwig Institute for Cancer Research has shown that the technology behind the Oxford-AstraZeneca COVID-19 vaccine has potential in treating cancer
Find out how other parts of the University are tackling COVID-19
Researchers across the University of Oxford are at the forefront of global efforts to understand COVID-19 and protect our communities.
Support our Research
Find out how to support Oxford's coronavirus work across a number of key research areas.